Innovation in Cardiovascular Disease Care & Coverage
Jen Norton, vice president and head of US Value & Access, Amgen, discusses challenges related to cardiovascular disease (CVD) management and how stakeholders across the health care industry can partner to close gaps in care and reduce costs.
About Jen Norton
Jen Norton is the vice president and head of US Value & Access at Amgen. She has nearly 2 decades of experience in pharmaceutical market access.
Current Challenges and Opportunities in the CVD Treatment Landscape
Jen Norton breaks down the challenges CVD presents for patients, payers, and providers, as well as opportunities for stakeholders to improve CVD management. Watch here.
The Patient Journey: Improving Access to CVD Care
Jen Norton shares how stakeholders across the health care system can collaborate to address the unmet needs of patients with CVD. Watch here.
Amgen’s Integrated Solutions to Help Improve CVD Care
Jen Norton reviews what Amgen has learned about closing gaps in cardiovascular care, improving outcomes, and reducing costs by partnering with payers and health systems. Watch here.
